Eyeworld

47 August 2016 EW REFRACTIVE Contact information Chang: dchang@empireeyeandlaser.com Reeves: swreeves@mneye.com Bloomington, Minnesota, likewise views the study as an interesting one that adds significantly to the literature on the topic. "They did it as double-masked and random- ized placebo-controlled, so it's a very well-written study and well conducted," he said. "That gives a lot of credibility to the results." While the younger population had a little bit better results, this was not surprising, he said, adding that both groups had significant improvement in their near vision. In the past, similar drops have unfortunately not passed muster, Dr. Reeves pointed out. "Part of the problem with some of the miotics in the past has been too much pupil- lary miosis," he said. "People were getting redness from the drop or brow ache." However, the combina- tion of carbachol and brimonidine allows some of the effects of brow aches and redness to be mitigated, he said, adding that the dosing could also be decreased a bit. Dr. Reeves thinks this could be an exciting potential option for presbyopia. "I think that this could potentially be very popular for patients because it's a liquid eye drop approach," Dr. Reeves said. "Use the drop in the morning and it lasts pretty much the working day and gives patients that extra near vi- sion." Also, given that this is a non- surgical approach, he thinks that a lot of patients would be interested if such a drop became available. Dr. Reeves' concern is that with miotics such as pilocarpine there's sometimes a small risk of retinal detachment. "I think that risk is quite low," he said, adding that high myopes might want to be a little more cautious for that reason. Overall, Dr. Reeves is optimistic about the approach. "I think this is an exciting avenue of development in the quest for presbyopia thera- py," he said, noting that there's the potential for a large market for this miotic approach. "It could be a nice option for a lot of patients at that initial (presbyopic) step." EW Reference 1. Abdelkader A. Improved presbyopic vision with miotics. Eye Contact Lens. 2015;41:323–7. Editors' note: Drs. Chang and Reeves have no financial interests related to their comments. www.malosa.com • Brand new Instruments, every time. • Zero cross-contamination risk. • Fixed procedure costs. Single-use instruments and procedure packs provide guaranteed patient safety at a lower cost. • Instruments & Procedure Packs. • Increased patient throughput. • Now available in the U.S.A. The specialists in single-use.

• Cover